RPL5 and breast cancer: Evidence to date suggests that RPL5 (along with numerous other ribosomal protein genes [RPGs]) is a haploinsufficient tumor suppressor gene which is frequently deleted in a range of cancers including glioblastoma multiforme, melanoma and breast cancer [23].